NGOMA, Rwanda, May 15, 2024 -/African Media Agency (AMA)/- On April 30, BGI Genomics and Rwanda Biomedical Center (RBC) launched a cervical most cancers screening program in Ngoma district , within the jap province of Rwanda. This program will present 20,000 human papillomavirus (HPV) DNA checks to ladies within the area, with the goal of strengthening cervical most cancers screening and prevention efforts and enhancing native testing capability precision medical.
The launching ceremony befell within the presence of Wang Xuekun, Chinese Ambassador to Rwanda; Mr. Pudence Rubingisa, Governor of the Eastern Province; Nathalie Niyonagira, mayor of the Ngoma district (Rwanda); Dr Albert Tuyishime, head of the HIV/AIDS illness prevention and management division at RBC; Dr. Theoneste Maniragaba, director of the most cancers illness unit at RBC; Du Yutao, basic director of BGI Genomics; Gao Zhiqiang, industrial advisor at RBC; Theoneste Maniragaba, director of the most cancers illnesses unit at RBC; Du Yutao, operations director of BGI Genomics; and Gao Zhiqiang, industrial advisor to the Rwandan embassy, amongst others.
Wang Xuekun, Chinese Ambassador to Rwanda
Wang Xuekun, Chinese Ambassador to Rwanda, mentioned: “BGI Genomics is a number one firm within the genomics sector, each in China and globally. The firm has made vital contributions to the promotion of friendship between China and Rwanda and the development of the medical and well being business in Rwanda.”
M. Pudence Rubingisa, Gouverneur of the jap province
Mr. Pudence Rubingisa, Governor of the Eastern Province, mentioned: “We vastly recognize our collaboration with BGI Genomics and different companions. As we launch this undertaking, we’re dedicated to leveraging all out there assets, together with native well being employees and businesses, to facilitate efficient screening and outreach and schooling efforts. This initiative is crucial to enhancing the well-being of our group.”
Dr. Albert Tuyishime, Head of HIV/AIDS Disease Prevention and Control Department at RBC
Dr Albert Tuyishime, Head of HIV/AIDS Disease Prevention and Control at RBC, mentioned: “Cervical most cancers is a significant world problem, notably in growing international locations the place Treatment choices are restricted. Rwanda goals to cleared the path in reaching world objectives to remove cervical most cancers. We worth our collaboration with BGI Genomics, which has improved testing companies in Ngoma district, and we sit up for increasing these companies throughout the nation.”
As the general public well being implementing company in Rwanda, RBC is dedicated to enhancing native public well being via scientific analysis, diagnostic companies and modern healthcare interventions . Under this initiative, BGI Genomics gives a whole answer together with laboratory gear and know-how switch, whereas all undertaking samples and check knowledge are processed by Rwandan employees and saved regionally in accordance with legal guidelines and rules. native rules. The firm will even assist enhance the native closed-loop administration system from cervical most cancers screening to optimistic intervention, which can considerably strengthen Rwanda’s healthcare infrastructure. The Chinese medical crew helping Rwanda helps the implementation of the cervical most cancers screening undertaking. Team chief Zhang Heping additionally attended the launch ceremony.
Cervical most cancers is the second commonest most cancers amongst ladies in Rwanda. According to knowledge from the Rwanda Health Management Information System (HMIS), solely 24% of eligible ladies in Rwanda have undergone cervical most cancers screening within the final 5 years.
According to the WHO pointers for screening and remedy of precancerous lesions of the cervix for the prevention of cervical most cancers, HPV DNA testing, with an accuracy charge of as much as 95 %, represent the screening methodology of first selection for the detection of cervical most cancers. A self-sampling mannequin is beneficial, by which ladies accumulate their check samples, adopted by centralized testing.
Dr. Du Yutao, Chief Operating Officer of BGI Genomics
“In China, HPV DNA testing know-how has been utilized in lots of large-scale public well being packages and achieved outstanding outcomes. We hope that cervical most cancers screening can reap the benefits of BGI Genomics’ know-how and self-sampling mannequin in international locations around the globe and assist speed up the purpose of eliminating cervical most cancers of the uterus worldwide,” mentioned Dr. Du Yutao, Chief Operating Officer of BGI Genomics.
HPV DNA testing merchandise developed by BGI Genomics are appropriate for large-scale inhabitants screening and correct genotyping of HPV. A single check screens for all 14 high-risk HPV sorts strongly correlated with the event of cervical most cancers, in keeping with WHO pointers, and is validated by large-scale scientific knowledge as appropriate for self-sampling.
Local employees practice eligible ladies in self-sampling strategies
A self-sampling mannequin requires only some medical employees to facilitate the fast assortment of quite a few samples, which vastly improves accessibility and successfully permits screening to cowl areas the place medical assets are restricted. This method notably gives vital advantages in distant areas of growing international locations the place chilly chain logistics are insufficient, because it minimizes the necessity for superior transportation and storage infrastructure. Ease of use, comfort and privateness will additional enhance screening protection.
In the long run, BGI Genomics plans to supply superior genetic testing applied sciences for reproductive well being, tumor screening and infectious illness prevention and management in Rwanda. This will promote world capability and effectivity in precision medication and assist enhance native medical and healthcare methods.
Distributed by African Media Agency (AMA) for BGI Genomics
About BGI Genomics and SENTIS HPV checks
BGI Genomics, headquartered in Shenzhen, China, is the world‘s main supplier of built-in precision medication options. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was formally listed on the Shenzhen Stock Exchange.
Le check SENTIS HPV check combines self-sampling know-how and genotyping assay to detect 14 most necessary, “high-risk” sorts of HPV, together with HPV -16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 and a couple of “low-risk” sorts of the virus, HPV -6, 11.
Media Contact:
Mia ZHAO BGI Genomics
The put up First African public well being initiative from BGI Genomics: Support for cervical most cancers screening for 20,000 Rwandans appeared first on African Media Agency.
Source : African Media Agency (AMA)